We are live on
!
Find out more
TCM
Twin Capital Management Portfolio holdings
AUM
$776M
1-Year Est. Return
28.34%
This Fund
S&P 500
This Quarter
Est. Return
-2.02%
1 Year Est. Return
+28.34%
3 Year Est. Return
+101.5%
5 Year Est. Return
+138.91%
10 Year Est. Return
+461.53%
AUM
$696M
AUM Growth
-$70.8M
(-9.2%)
Cap. Flow
-$49.5M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
29.64%
Holding
297
New
13
Increased
50
Reduced
204
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$2.5M |
| 2 |
Illumina
ILMN
|
+$2.08M |
| 3 |
Analog Devices
ADI
|
+$1.89M |
| 4 |
Oracle
ORCL
|
+$1.86M |
| 5 |
Carlyle Group
CG
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.83M |
| 2 |
Microsoft
MSFT
|
+$5.18M |
| 3 |
Nike
NKE
|
+$4.58M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$3.51M |
| 5 |
Costco
COST
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Healthcare | 13.9% |
| 3 | Financials | 12.14% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.41% |
Similar funds
BPIM
PC
PA
AC
SC
VNA
PGA
CCA
Twin Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Twin Capital Management held 297 positions worth $696M, down 9.2% from $767M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Twin Capital Management withdrew a net $49.5M in Q3 2023, closing 20 positions and reducing 204 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $3.51M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Twin Capital Management opened a new position in Stryker worth $2.38M.
- Twin Capital Management's largest Q3 2023 buy was Stryker: 8,701 shares worth $2.38M.
- Twin Capital Management added most to Analog Devices in Q3 2023, an estimated $1.89M increase.
- Twin Capital Management's biggest Q3 2023 reduction was Apple, cutting an estimated $6.83M.
- Twin Capital Management fully exited Thermo Fisher Scientific in Q3 2023, selling an estimated $3.51M.
- Twin Capital Management's ten largest holdings make up 30% of its $696M portfolio in Q3 2023.
- Twin Capital Management opened 13 new positions and closed 20 in Q3 2023.
- Twin Capital Management's portfolio value fell 9.2% quarter-over-quarter to $696M.
Based on Twin Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.